PubRank

M Neidhart

Author PubWeight™ 23.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Arthritis Rheum 2001 1.39
2 Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol 1998 1.22
3 The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 2007 1.05
4 DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 2011 1.04
5 Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum 2000 0.99
6 Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury. Rheumatol Int 1998 0.99
7 Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. Ann Rheum Dis 2005 0.99
8 Adult human chondrocytes cultured in alginate form a matrix similar to native human articular cartilage. Am J Physiol 1996 0.98
9 S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann Rheum Dis 2006 0.96
10 Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids. Br J Rheumatol 1998 0.95
11 Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis. Gene Ther 2004 0.94
12 MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritis. Rheumatology (Oxford) 1999 0.94
13 p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion. Ann Rheum Dis 2003 0.93
14 [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts]. Z Rheumatol 2001 0.89
15 Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis. J Rheumatol 2001 0.87
16 Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants. Psychosomatics 1987 0.87
17 Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways. Ann Rheum Dis 2004 0.83
18 Retrovirus-associated rheumatic syndromes. Curr Opin Rheumatol 1998 0.81
19 Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 1988 0.80
20 Cartilage destruction in rheumatoid arthritis. Ann Rheum Dis 2002 0.79
21 Prevalence of TTV DNA and GBV-C RNA in patients with systemic sclerosis, rheumatoid arthritis, and osteoarthritis does not differ from that in healthy blood donors. Ann Rheum Dis 2001 0.78
22 Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis Rheum 2010 0.77
23 Adaptation of contractile proteins in human heart and skeletal muscles. Biomed Biochim Acta 1989 0.76
24 Altered diurnal rhythm of prolactin in systemic sclerosis. J Rheumatol 2000 0.76
25 [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis]. Z Rheumatol 1999 0.75
26 The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands. Ann Rheum Dis 2007 0.75
27 Gene transfer of protective cytokines in rheumatoid arthritis. Adv Exp Med Biol 2001 0.75
28 [Polymyositis: disease course and therapy with intravenously administered immunoglobulins]. Schweiz Med Wochenschr 1992 0.75
29 [Cerebral protection by retrograde perfusion in the treatment of acute aortic dissection]. Presse Med 1994 0.75